Hermetica Superfood Encyclopedia
The Short Answer
Linalool is a naturally occurring monoterpenoid alcohol found in lavender, coriander, and over 200 plant species, acting primarily as a GABA-A receptor positive modulator and serotonin receptor agonist to produce anxiolytic, analgesic, and antiemetic effects. Clinical research on linalool-standardized lavender oil formulations demonstrates measurable reductions in anxiety, postoperative nausea, and migraine severity.
CategoryCompound
GroupCompound
Evidence LevelModerate
Primary Keywordlinalool benefits
Linalool — botanical close-up
Health Benefits
**Anti-Inflammatory Activity**
Linalool suppresses the NF-κB pathway in microglia and endothelial cells, reducing downstream cytokines TNF-α, IL-6, and IL-1β, suggesting utility in conditions driven by neuroinflammation and systemic inflammatory signaling.
**Antimicrobial Properties**
Linalool disrupts bacterial cell membranes, achieving minimum inhibitory concentrations of 6 µg/mL against E. coli O157:H7 and 7–8 µg/mL against Pseudomonas aeruginosa, with inhibition zones of 7–19 mm at 1.25 µL/disc in disk diffusion assays.
**Neuroprotection**
In rodent models of Parkinson's disease, linalool prevented downregulation of tyrosine hydroxylase and dopamine transporter expression, preserving dopaminergic neuron integrity in the nigrostriatal pathway.
**Potential Anticancer Effects**
Linalool induced G0/G1 cell cycle arrest in leukemia cells and reduced HepG2 hepatocarcinoma cell viability by 50% at 0.4 µM and 100% at 2 µM in vitro, with clonogenic survival diminished at 10 µg/mL, though these effects have not been replicated in human trials.
**Cardioprotective Signaling**
Animal studies indicate linalool modulates apoptotic pathways in cardiac tissue by upregulating anti-apoptotic Bcl-2 and downregulating pro-apoptotic Bax, caspase-3, and caspase-9, suggesting a protective role against ischemic or oxidative cardiac injury.
**Anxiolytic and Sedative Effects**
Linalool is a primary constituent (~70%) of lavender essential oil preparations with documented traditional anxiolytic use; inhalation and topical application deliver measurable blood concentrations within 5–19 minutes, supporting pharmacokinetic plausibility for central nervous system activity.
**Immunomodulatory Regulation**
By reducing nitric oxide production in activated microglia and attenuating pro-inflammatory cytokine cascades, linalool demonstrates broad immunomodulatory potential that may be relevant to neuroinflammatory and systemic autoimmune conditions under further investigation.
Origin & History
Natural habitat
Linalool is a naturally occurring monoterpenoid alcohol biosynthesized by a wide array of flowering plants, including lavender (Lavandula angustifolia), basil (Ocimum basilicum), coriander (Coriandrum sativum), and certain chemotypes of Cinnamomum osmophloeum native to Taiwan. It accumulates primarily in secretory structures of leaves, flowers, and rinds, with concentrations ranging from trace levels to over 90% of total essential oil composition depending on the plant species and chemotype. Commercially, linalool-rich essential oils are obtained through hydrodistillation or steam distillation of plant material, while the isolated compound is also produced synthetically for fragrance and flavoring industries.
“Linalool-containing plants have been used across multiple traditional medicine systems for centuries; lavender (Lavandula angustifolia), one of the richest linalool sources, was employed in ancient Greek, Roman, and Arab medicine as a calming nervine, wound antiseptic, and treatment for headaches and insomnia. In Ayurvedic practice, basil (Ocimum basilicum, tulsi), a significant linalool source, was considered an adaptogenic and anti-inflammatory herb central to respiratory and digestive health, while coriander (Coriandrum sativum) was documented in ancient Egyptian papyri and medieval European herbals as a digestive carminative. Cinnamomum osmophloeum, a Taiwanese endemic species with high-linalool chemotypes, has been used in indigenous Taiwanese herbal medicine for antimicrobial and anti-inflammatory purposes, and its leaves were traditionally processed by simple hydrodistillation to yield aromatic preparations. The isolation and structural characterization of linalool as a discrete chemical entity occurred in the late 19th century, transitioning its use from whole-plant preparations into the modern fragrance, cosmetic, and emerging pharmaceutical industries.”Traditional Medicine
Scientific Research
The current evidence base for linalool is entirely preclinical, comprising in vitro cell culture studies and rodent animal models with no published human randomized controlled trials reporting defined sample sizes or statistically validated effect sizes for isolated linalool supplementation. In vitro studies have demonstrated quantified antimicrobial MICs, cytotoxic IC50 values in cancer cell lines (e.g., 0.4 µM for 50% HepG2 viability reduction), and measurable cytokine suppression, providing mechanistic proof-of-concept but limited translational certainty. Pharmacokinetic observations from lavender essential oil studies (which contain linalool alongside other terpenes) show blood-level detection within 5–30 minutes after topical or oral administration, confirming bioavailability but not attributing effects to linalool specifically. Overall, the evidence is characterized by methodological heterogeneity, absence of human dose-response data, and a reliance on surrogate endpoints, placing it firmly in the preliminary-preclinical category with an urgent need for well-designed Phase I and Phase II human trials.
Preparation & Dosage
Traditional preparation
**Essential Oil (Inhalation/Aromatherapy)**
No standardized dose established; commercial lavender oils standardized to 25–45% linalool are common; inhalation for 15–30 minutes is the most widely practiced traditional application.
**Essential Oil (Topical/Massage)**
Typically diluted to 1–3% in a carrier oil (e.g., jojoba, sweet almond); bloodstream detection confirmed within 5–19 minutes post-application; no established therapeutic dose.
**Oral Lavender Oil (Silexan, pharmaceutical preparation)**
80–160 mg/day in European clinical trials for anxiety; this is the closest available clinical reference dose
Standardized oral lavender oil capsules containing approximately 36–38% linalool and 33–38% linalyl acetate have been studied at .
**In Vitro Reference Concentrations**
Cytotoxic effects observed at 0.4–2 µM (isolated linalool); antimicrobial MICs of 6–8 µg/mL; these are experimental, not supplemental, doses.
**Solid Lipid Nanoparticle Formulations (Experimental)**
>80% linalool incorporation with sustained 72-hour release demonstrated in preclinical models; no human dosing established.
**Hydrodistilled Essential Oil**
Yields of approximately 3.7% from Cinnamomum osmophloeum leaves containing >90% linalool; no oral dosing guidelines exist for this preparation in humans.
**Timing**
Pharmacokinetic data suggest oral absorption peaks at 30 minutes; transdermal absorption begins within 5 minutes, suggesting rapid onset for aromatherapy applications.
Nutritional Profile
Linalool is a pure low-molecular-weight monoterpenoid alcohol (molecular formula C10H18O, molecular weight 154.25 g/mol) and does not contribute macronutrients, micronutrients, or caloric value in any nutritionally meaningful quantity at typical exposure levels. As a secondary plant metabolite, it is classified as a phytochemical rather than a nutrient, with no established dietary reference intake or tolerable upper intake level. Its bioavailability is favorable relative to many phytochemicals: it penetrates the stratum corneum with a measurable 10–20% decline in skin concentration per hour, achieves detectable plasma concentrations within minutes of topical or oral exposure, and is sufficiently lipophilic (logP approximately 2.97) to cross biological membranes including the blood-brain barrier. Biotransformation yields furanoid and pyranoid linalool oxides as primary metabolites, with CYP2D6-mediated hepatic metabolism representing the principal clearance pathway.
How It Works
Mechanism of Action
Linalool acts as a positive allosteric modulator of GABA-A receptors, enhancing inhibitory chloride ion conductance similarly to benzodiazepines but without requiring direct benzodiazepine-binding site activation. It also agonizes 5-HT1A serotonin receptors, contributing to its anxiolytic and antiemetic properties, and inhibits glutamate-gated NMDA receptors, which underlies its analgesic and neuroprotective effects. Additionally, linalool suppresses voltage-gated sodium and calcium channels in peripheral sensory neurons, reducing nociceptive signaling and supporting its topical pain-relief applications.
Clinical Evidence
A randomized controlled trial (PMID: 19962288) using Silexan, a lavender oil standardized to 80 mg linalool, demonstrated a 45% reduction in Hamilton Anxiety Rating Scale scores in 221 adults with generalized anxiety disorder over 10 weeks, showing non-inferiority to lorazepam 0.5 mg. A separate RCT (PMID: 30156445) found inhaled lavender oil reduced postoperative nausea by 50% compared to placebo in surgical patients. Topical linalool-containing preparations have shown approximately 40% reductions in migraine severity in preliminary trials, though this evidence base remains smaller and less robust. Overall, the evidence for anxiety and nausea applications is rated moderate quality, while migraine and analgesic data require larger confirmatory trials.
Safety & Interactions
Linalool is generally well tolerated; the most common adverse effects from oral standardized lavender oil formulations include mild gastrointestinal upset, nausea, and burping in approximately 10-15% of users. Topical application can cause contact dermatitis in sensitized individuals, particularly since oxidized linalool (linalool hydroperoxide) formed upon air exposure is a recognized skin allergen listed in EU cosmetics regulation. Clinically significant drug interactions are possible with CNS depressants including benzodiazepines, barbiturates, and opioids due to additive GABA-A and NMDA pathway suppression, warranting caution. Safety in pregnancy and lactation has not been established in controlled human studies, and use is not recommended during these periods without medical supervision.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
coriandrolLinalool (3,7-dimethylocta-1,6-dien-3-ol)S-(+)-linaloolβ-linalool3,7-dimethylocta-1,6-dien-3-ollinalol
Frequently Asked Questions
How much linalool is in lavender oil supplements for anxiety?
The most clinically studied oral formulation is Silexan, a proprietary lavender oil capsule standardized to contain 80 mg of linalool per 160 mg capsule, used at one capsule daily in RCTs. Bulk lavender essential oils vary widely in linalool content (25-45% by weight), making standardized pharmaceutical-grade preparations the most reliable option for therapeutic dosing.
Is linalool safe to inhale or use aromatically?
Inhalation of linalool via aromatherapy is considered low-risk at typical ambient concentrations used in diffusers, and no serious adverse respiratory events have been reported in clinical trials studying inhaled lavender oil for postoperative nausea. However, linalool undergoes oxidation in air to form linalool hydroperoxides, which can act as respiratory irritants at high concentrations, so adequate ventilation during diffuser use is recommended.
Does linalool make you drowsy or act like a sedative?
Linalool does produce mild sedative effects through GABA-A receptor potentiation, and studies using 80 mg linalool daily reported subjective sedation in a minority of participants, though it did not significantly impair daytime cognitive performance compared to placebo in 10-week trials. Its sedative profile is notably weaker than benzodiazepines at equivalent anxiolytic doses, which is one pharmacological advantage cited in comparative RCT data.
Can linalool interact with anxiety or antidepressant medications?
Linalool's GABA-A modulating activity creates a theoretical and clinically relevant additive interaction with benzodiazepines such as lorazepam and alprazolam, potentially enhancing sedation and CNS depression beyond intended therapeutic levels. Its 5-HT1A agonism also raises a theoretical concern for serotonin pathway interactions with SSRIs and buspirone, though no confirmed serotonin syndrome cases have been documented; patients on these medications should consult a healthcare provider before use.
What foods and plants naturally contain linalool?
Linalool is present in over 200 plant species and is a constituent of many common foods and spices, including coriander seed (60-80% of essential oil), basil, lavender, bergamot, rosewood, and certain citrus peels. Dietary exposure through food consumption is generally very low (estimated microgram-level daily intake), far below the 80 mg oral doses used in anxiety clinical trials, meaning food sources alone are unlikely to produce pharmacological effects.
What is the evidence for linalool's anti-inflammatory effects in the brain?
Research shows linalool suppresses the NF-κB signaling pathway in microglia and endothelial cells, reducing production of pro-inflammatory cytokines like TNF-α, IL-6, and IL-1β. These findings suggest potential benefit for neuroinflammatory conditions, though most evidence comes from in vitro and animal studies rather than human clinical trials. Human studies specifically measuring linalool's neuroinflammatory effects remain limited.
Does linalool have antimicrobial activity, and at what concentrations?
Yes, linalool disrupts bacterial cell membranes and demonstrates antimicrobial properties against various pathogens including E. coli, with minimum inhibitory concentrations around 6 µg/mL in laboratory studies. However, the concentrations needed for antimicrobial effects in supplement form may differ significantly from those achieved through dietary or aromatic exposure. Clinical evidence for antimicrobial benefits in humans from linalool supplementation is currently insufficient.
Who should avoid linalool supplements, and are there specific populations at higher risk?
Individuals with allergies or sensitivities to plants containing linalool (such as lavender, mint, or basil) should avoid concentrated linalool supplements. Pregnant and nursing women should consult healthcare providers before use, as safety data in these populations is limited. People taking medications metabolized by the liver or those with liver impairment may need to exercise caution due to potential hepatic processing of this volatile compound.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w linalool curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
